Clorox (NYSE:CLX) Releases Earnings Results, Beats Expectations By $0.48 EPS

Posted by Stanley Muller on Nov 4th, 2026

Clorox (NYSE:CLX – Get Free Report) issued its quarterly earnings data on Monday. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.48, FiscalAI reports. Clorox had a net margin of 9.41% and a return on equity of 601.88%. The business had revenue of $1.91 billion during the quarter, compared to analysts’ expectations of $1.88 billion. During the same quarter in the previous year, the company earned $0.85 EPS. The business’s revenue was up 33.3% on a year-over-year basis.

Here are the key takeaways from Clorox’s conference call:

First-quarter performance exceeded expectations, with improving organic sales trends, consumption, and aggregate market share. Home care gained more than half a share point, while Hidden Valley gained nearly two points and Kingsford posted strong Labor Day growth.
The company raised its fiscal 2027 input-cost inflation estimate to approximately $240 million, about $40 million above its initial outlook, driven by resin, commodities, transportation, and broader supply-chain costs. Margin pressure is expected to be greatest in the first half.
Full-year organic sales growth is projected at 3.5%–4.5%, including roughly 3.5 points from lapping the ERP transition; excluding that benefit, growth is expected to be flat to up 1%. Management anticipates slightly weaker results in the first half and modest improvement in the back half, supported by innovation and execution.
Management expects productivity and cost savings to provide most of the margin recovery, supplemented by targeted pricing and revenue-growth-management actions. Clorox has line of sight to at least $50 million of GOJO cost synergies, with some benefits arriving earlier than initially expected.
CEO Linda Rendle will step down on January 5, with Fabian Garcia appointed as her successor. Management expects a smooth transition, with Garcia bringing consumer-products experience in brand building, innovation, portfolio management, and disciplined growth.

Clorox Price Performance

NYSE:CLX traded up $7.17 during mid-day trading on Wednesday, reaching $100.97. The stock had a trading volume of 1,415,462 shares, compared to its average volume of 2,650,483. Clorox has a 12 month low of $79.12 and a 12 month high of $128.90. The stock has a market capitalization of $12.21 billion, a PE ratio of 18.13, a P/E/G ratio of 3.00 and a beta of 0.59. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38. The stock has a 50-day simple moving average of $88.00 and a two-hundred day simple moving average of $99.83.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Wednesday, October 28th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox’s dividend payout ratio (DPR) is 103.73%.

Analysts Set New Price Targets

CLX has been the subject of a number of analyst reports. Morgan Stanley dropped their price target on shares of Clorox from $97.00 to $87.00 and set an “equal weight” rating for the company in a research report on Thursday, October 15th. Citigroup dropped their price objective on Clorox from $97.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, October 14th. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a report on Thursday, October 29th. UBS Group set a $88.00 price target on Clorox in a research report on Tuesday. Finally, Jefferies Financial Group cut Clorox from a “buy” rating to a “hold” rating and decreased their price target for the stock from $125.00 to $98.00 in a research report on Tuesday, July 28th. One investment analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat, Clorox currently has an average rating of “Reduce” and an average price target of $93.29.

Read Our Latest Analysis on CLX

Trending Headlines about Clorox

Here are the key news stories impacting Clorox this week:

Positive Sentiment: Clorox reported adjusted EPS of $1.55, above the $1.07 consensus, and revenue of $1.91 billion, topping estimates of $1.88 billion. Higher sales, cost savings and contributions from GOJO supported the results. Clorox Shares Rally After Q1 Earnings Beat
Positive Sentiment: The company maintained fiscal 2027 guidance of $5.70–$6.00 in adjusted EPS and $7.6–$7.7 billion in revenue, with the EPS range slightly above consensus. Evercore also upgraded its rating to In-Line from Underperform, citing the new CEO’s turnaround experience. Evercore ISI Group upgrades Clorox to in-line
Neutral Sentiment: Analyst views remain mixed: UBS raised its price target to $96 while keeping a Neutral rating; Barclays maintained a Sell rating. UBS adjusts Clorox price target
Negative Sentiment: Clorox expects adjusted earnings near the low end of its fiscal-year range as inflation and higher input costs squeeze margins. The acquisition-related increase in debt has also prompted questions about balance-sheet flexibility and dividend sustainability. Clorox earnings outlook and costs

About Clorox

(Get Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.

Earnings History for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.